Delivery Order SPE2DB20D1100-SPE2DB25FC0Y2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,558.78 for 120 tablets of Erleada 60 mg on September 3, 2025, with completion expected by September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,117.58 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a $7,352.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) under contract number 4569037002. The delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action stemming from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $37,793.90 for 120-count supplies of Erleada 60 mg tablets, with an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with a firm fixed price structure. The delivery order is set to be completed by September 16, 2025, and represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Erleada 60 mg tablets in a quantity of 120 units. This firm fixed-price delivery order, valued at $7,558.78, is scheduled for completion by September 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was awarded through open competition. This delivery...
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Erleada 240 mg tablets (quantity: 30 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 1, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) under a firm fixed-price contract with an ultimate completion date of October 8, 2025. This competitively awarded, non-set-aside delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0Y2Delivery Order
The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) with an ultimate completion date of May 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen provides critical medical supplies to military and veteran healthcare systems, including specialty medications, branded and generic drugs, and medical devices across multiple therapeutic domains. The contract reflects the company's established capability to fulfill federal medical procurement requirements through open competition and supports the Defense Logistics Agency's pharmaceutical distribution network serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 5/2/25 |